SBI Healthcare Opportunities Fund
The fund remains heavily skewed toward large-cap pharma and biotech, with Sun Pharma and Divi's anchoring a concentrated portfolio where the top five holdings command over a third of assets. The recent exit of smaller diagnostic and specialty pharma plays signals the manager is trimming lower-conviction positions while maintaining bullish pharma exposure, as evidenced by the strong 9.2% monthly gain. With two-thirds of capital in drugs and chemicals, this fund bets on India's pharmaceutical export momentum and domestic healthcare consumption, though concentration risk warrants caution for risk-averse investors.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Direct Growth | ₹527.9082 | +8.38% | — | — | — | — | — |
| Regular Growth | ₹457.2003 | +8.29% | +9.51% | +5.35% | +9.96% | +26.07% | +15.71% |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. INE044A01036 | 11.71% |
| 2 | Divi's Laboratories Ltd. INE361B01024 | 6.77% |
| 3 | Acutaas Chemicals Ltd. INE00FF01025 | 5.40% |
| 4 | Apollo Hospitals Enterprise Ltd. INE437A01024 | 5.30% |
| 5 | Max Healthcare Institute Ltd. INE027H01010 | 5.17% |
| 6 | Aster DM Healthcare Ltd. INE914M01019 | 3.89% |
| 7 | Lupin Ltd. INE326A01037 | 3.84% |
| 8 | Torrent Pharmaceuticals Ltd. INE685A01028 | 3.48% |
| 9 | Anthem Biosciences Ltd. INE0CZ201020 | 3.45% |
| 10 | Aether Industries Ltd. INE0BWX01014 | 3.35% |
| 11 | Mankind Pharma Ltd. INE634S01028 | 3.33% |
| 12 | Aurobindo Pharma Ltd. INE406A01037 | 3.21% |
| 13 | Fortis Healthcare Ltd. INE061F01013 | 3.20% |
| 14 | Biocon Ltd. INE376G01013 | 3.12% |
| 15 | Laurus Labs Ltd. INE947Q01028 | 3.06% |
| 16 | Lonza Group US54338V1017 | 2.71% |
| 17 | TREPS | 2.68% |
| 18 | Jupiter Life Line Hospitals Ltd. INE682M01012 | 2.55% |
| 19 | Alkem Laboratories Ltd. INE540L01014 | 2.50% |
| 20 | Sai Life Sciences Ltd. INE570L01029 | 2.47% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.